Literature DB >> 8760041

Angiotensin II type 1 receptor modulation of neuronal K+ and Ca2+ currents: intracellular mechanisms.

C Sumners1, M Zhu, C H Gelband, P Posner.   

Abstract

Angiotensin II (ANG II) elicits an ANG II type 1 (AT1) receptor-mediated decrease in voltage-dependent K+ current (Ik) and an increase in voltage-dependent Ca2+ current (ICa) in neurons cocultured from newborn rat hypothalamus and brain stem. Modulation of these currents by ANG II involves intracellular messengers that result from an AT1 receptor-mediated stimulation of phosphoinositide hydrolysis. For example, the effects of ANG II on IK and ICa were abolished by phospholipase C antagonists. The reduction in IK produced by ANG II was attenuated by either protein kinase C (PKC) antagonists or by chelation of intracellular Ca2+. By contrast, PKC antagonism abolished the stimulatory effect of ANG II on ICa. Superfusion of the PKC activator phorbol 12-myristate 13-acetate produced effects on IK and ICa similar to those observed after ANG II. Furthermore, intracellular application of inositol 1,4,5-trisphosphate (IP3) elicited a significant reduction in IK. This suggests that the AT1 receptor-mediated changes in neuronal K+ and Ca2+ currents involve PKC (both IK and ICa) and IP3 and/or intracellular Ca2+ (IK).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760041     DOI: 10.1152/ajpcell.1996.271.1.C154

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.

Authors:  Krupa Savalia; Devika S Manickam; Erin G Rosenbaugh; Jun Tian; Iman M Ahmad; Alexander V Kabanov; Matthew C Zimmerman
Journal:  Free Radic Biol Med       Date:  2014-06-09       Impact factor: 7.376

2.  Chronic angiotensin II infusion attenuates the renal sympathoinhibitory response to acute volume expansion.

Authors:  Lila P LaGrange; Glenn M Toney; Vernon S Bishop
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-04       Impact factor: 3.619

3.  BDNF downregulates β-adrenergic receptor-mediated hypotensive mechanisms in the paraventricular nucleus of the hypothalamus.

Authors:  Daniella Thorsdottir; Nicholas C Cruickshank; Zachary Einwag; Grant W Hennig; Benedek Erdos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-11       Impact factor: 4.733

4.  Selective potentiation of N-type calcium channels by angiotensin II in rat subfornical organ neurones.

Authors:  D L Washburn; A V Ferguson
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

5.  Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases.

Authors:  Jimmy Delaney; Roselynn Chiarello; David Villar; Umadevi Kandalam; Ana Maria Castejon; Michelle A Clark
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

Review 6.  Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.

Authors:  Shereeni J Veerasingham; Mohan K Raizada
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

7.  Diminished A-type potassium current and altered firing properties in presympathetic PVN neurones in renovascular hypertensive rats.

Authors:  Patrick M Sonner; Jessica A Filosa; Javier E Stern
Journal:  J Physiol       Date:  2008-01-31       Impact factor: 5.182

8.  Dual mechanisms of angiotensin-induced activation of mouse sympathetic neurones.

Authors:  X Ma; K Bielefeldt; Z Y Tan; C A Whiteis; V Snitsarev; F M Abboud; M W Chapleau
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

Review 9.  The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure.

Authors:  Irving H Zucker; Liang Xiao; Karla K V Haack
Journal:  Clin Sci (Lond)       Date:  2014-05       Impact factor: 6.124

Review 10.  Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

Authors:  Erin G Rosenbaugh; Krupa K Savalia; Devika S Manickam; Matthew C Zimmerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.